Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: Newer antipsychotics are increasingly used in schizophrenia maintenance. The UK change has been slow with little known on switching patterns. We aimed to investigate antipsychotic prescribing patterns in schizophrenia patients. METHOD: A naturalistic six-site cohort sample of 600 patients were interviewed by researchers at 6-monthly intervals for 2 years to record their clinical and social functioning; use of services and medication for the preceding 6 months was obtained by structured extraction from clinical case notes. RESULTS: Alterations in antipsychotic medication were frequent in this group, mainly during periods of inpatient care. Atypical prescribing increased steadily, though slowly, across the period. Polypharmacy was less than anticipated. CONCLUSION: Inpatient care remains the main forum for switching of antipsychotics. The UK maintains a slow shift to atypical antipsychotics.

Original publication




Journal article


Acta Psychiatr Scand

Publication Date





126 - 134


Adult, Aged, Aged, 80 and over, Ambulatory Care, Antipsychotic Agents, Cohort Studies, Diffusion of Innovation, Drug Prescriptions, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Long-Term Care, Male, Middle Aged, Psychotic Disorders, Rural Health, Schizophrenia, Socioeconomic Factors, United Kingdom, Urban Health